Evidence map›Paper›PMID 37116934›Full record

ArticleGlobal health, science and practice2023

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV.

Theodore Ruel, Martina Penazzato, Jennifer M Zech, Moherndran Archary, Tim R Cressey, Ameena Goga, Joseph Harwell, Raphael J Landovitz, Maria Grazia Lain, Marc Lallemant and 6 more

Abstract read
In one paragraph

Article in Global health, science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Theodore RuelUniversity of California, San Francisco, San Francisco, CA, USA.
Martina PenazzatoWorld Health Organization, Geneva, Switzerland.
Jennifer M ZechICAP at Columbia University, Mailman School of Public Health, Columbia University, NY, USA.
Moherndran ArcharyUniversity of KwaZulu-Natal, Durban, South Africa.
Tim R CresseyAMS-IRD Research Collaboration, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Ameena GogaHIV and other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.
Joseph HarwellClinton Health Access Initiative, Boston, MA, USA.
Raphael J LandovitzUCLA Center for Clinical AIDS Research and Education, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Maria Grazia LainFundação Ariel Glaser contra o SIDA Pediátrico, Maputo, Mozambique.
Marc LallemantAMS-PHPT Research Collaboration, Chiang Mai University, Chiang Mia, Thailand.
Eleanor Namusoke-MagongoPaediatric and Adolescent HIV Care Treatment Branch, Ministry of Health, Kampala, Uganda.
Irene MukuiDrugs for Neglected Diseases Initiative, Nairobi, Kenya.
Sallie R PermarDepartment of Pediatrics, Weill Cornell Medicine, New York, NY, USA.
Andrew J PrendergastQueen Mary University of London, London, United Kingdom.
Roger ShapiroDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Elaine J AbramsICAP at Columbia University, Mailman School of Public Health, Columbia University, NY, USA.

Funding

LOC-IMPAACT Leadership GroupPharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant Women in the USUM1AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI Jennifer Jao, Sharon A Nachman · 2011 to 2026
$278.1M
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTGUM1AI068616 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Sean Scott Brummel, Marlene Ann Cooper · 2011 to 2026
$155.6M
UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RAPHAEL J LANDOVITZ · 1997 to 2026
$53.5M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
Medical Research Council G0500384NIAID NIH HHS UM1 AI068616NIAID NIH HHS UM1 AI068632NIAID NIH HHS UM1 AI106716NICHD NIH HHS HHSN275201800001CNICHD NIH HHS HHSN275201800001INIMH NIH HHS P30 MH058107Wellcome TrustWellcome Trust 108065/Z/15/ZWorld Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsHIV InfectionsBreast FeedingFemaleHumansInfantInfectious Disease Transmission, VerticalAnti-HIV Agents

Identifiers

PMID37116934
PMCPMC10141432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.